Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

BACKGROUND: Median OS after surgery in curative intent for non-metastasized pancreas cancer ranges under study conditions from 17.9 months to 23.6 months. Tumor recurrence occurs locally, at distant sites (liver, peritoneum, lungs), or both. Observational and autopsy series report local recurrence r...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Tachezy, Michael, Gebauer, Florian, Petersen, Cordula, Arnold, Dirk, Trepel, Martin, Wegscheider, Karl, Schafhausen, Phillipe, Bockhorn, Maximilian, Izbicki, Jakob Robert, Yekebas, Emre
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Study Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057592/
https://ncbi.nlm.nih.gov/pubmed/24906700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-411
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים